Chester County News and Community Website
MOUNTVILLE, PA — Field of Screams turned adrenaline and community spirit into tangible impact this fall, raising $8,400 for the Pennsylvania Breast Cancer Coalition during its 13th annual Zombie Fun …
Zombies, Mud, and a Cause: Field of Screams Run Raises $8,400 for Cancer Care Read More
WILMINGTON, DE — In a major advance for breast cancer treatment, AstraZeneca and Daiichi Sankyo announced that their drug DATROWAY (datopotamab deruxtecan-dlnk) extended the lives of patients with metastatic triple-negative …
Breakthrough Drug Shows Unprecedented Survival Gains in Aggressive Breast Cancer Read More
WILKES-BARRE, PA — The Shapiro Administration on Tuesday spotlighted a new artificial intelligence program being used at Geisinger Wyoming Valley Medical Center to identify women at high risk for breast …
Pennsylvania Expands Use of AI in Breast Cancer Detection, Aims to Boost Early Diagnosis and Save Lives Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported that their antibody-drug conjugate ENHERTU® (fam-trastuzumab deruxtecan-nxki), when used before surgery and followed by standard therapy, achieved a pathologic complete response in …
ENHERTU Combination Shows Promising Results in Early Breast Cancer Trial Read More
ANNAPOLIS, MD & PHILADELPHIA, PA — Unite for HER and TOUCH, The Black Breast Cancer Alliance (TOUCHBBCA), have announced the 2025 Care for HER program, an initiative aimed at reducing …
Unite for HER and TOUCHBBCA Expand Care for Black Breast Cancer Patients With 2025 Program Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) last week added breast cancer treatment and genetic/familial high-risk assessment to its NCCN Guidelines Navigator™ platform, broadening access to digitized, …
NCCN Expands Digital Navigator With New Breast Cancer and Genetic Risk Resources Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported that their drug ENHERTU® (fam-trastuzumab deruxtecan-nxki) achieved highly statistically significant and clinically meaningful improvements in invasive disease-free survival (IDFS) compared to trastuzumab …
ENHERTU Shows Strong Results in Early Breast Cancer Trial Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced new funding to support quality improvement projects aimed at advancing breast cancer outcomes. The …
NCCN Oncology Research Program Announces New Funding for Breast Cancer Quality Initiatives Read More
AUDUBON, PA — CertaPro Painters® has launched its seventh annual Paint it Pink campaign in partnership with the Breast Cancer Research Foundation (BCRF) and Breast Cancer Canada, continuing its mission …
CertaPro Painters Launches Seventh Annual ‘Paint It Pink’ Campaign for Breast Cancer Research Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to their supplemental Biologics License Application (sBLA) for …
FDA Grants Priority Review for ENHERTU Combo in Advanced Breast Cancer Read More